Liv Sagatun
Publications
2020
-
Jørgensen, Kristin Kaasen;
Goll, Guro Løvik;
Sexton, Joseph;
Bolstad, Nils;
Olsen, Inge Christoffer;
Asak, Øivind Wessel.
(2020)
Efficacy and safety of CT-P13 in inflammatory bowel disease after switching from originator infliximab: Exploratory analyses from the NOR-SWITCH main and extension trials.
BioDrugs
Academic article
2017
-
Mjønes, Patricia;
Sagatun, Liv;
Nordrum, Ivar Skjåk;
Waldum, Helge.
(2017)
Neuron-Specific Enolase as an Immunohistochemical
Marker Is Better Than Its Reputation.
Journal of Histochemistry and Cytochemistry
Academic article
-
Mjønes, Patricia;
Nordrum, Ivar Skjåk;
Sørdal, Øystein Finset;
Sagatun, Liv;
Fossmark, Reidar;
Sandvik, Arne Kristian.
(2017)
Expression of the cholecystokinin-B receptor in neoplastic gastric cells.
Discover Oncology
Academic article
-
Waldum, Helge;
Sagatun, Liv;
Mjønes, Patricia.
(2017)
Gastrin and gastric cancer.
Frontiers in Endocrinology
Academic article
2016
-
Sagatun, Liv;
Mjønes, Patricia Gjertrud;
Jianu, Constantin-Sergiu;
Boyce, Malcolm;
Waldum, Helge Lyder;
Fossmark, Reidar.
(2016)
The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: Review of long-term treatment.
European Journal of Gastroenterology and Hepathology
Academic article
-
Boyce, Malcolm;
Moore, Andrew;
Sagatun, Liv;
Parsons, Bryony;
Varro, Andrea;
Campbell, Fiona.
(2016)
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
British Journal of Clinical Pharmacology
Academic article
-
Sagatun, Liv;
Fossmark, Reidar;
Jianu, Constantin-Sergiu;
Qvigstad, Gunnar;
Nordrum, Ivar Skjåk;
Mjønes, Patricia.
(2016)
Follow-up of patients with ECL cell-derived tumours.
Scandinavian Journal of Gastroenterology
Academic article
2015
-
Fossmark, Reidar;
Sagatun, Liv;
Nordrum, Ivar Skjåk;
Sandvik, Arne Kristian;
Waldum, Helge.
(2015)
Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival.
APMIS - Journal of Pathologiy, Microbiology and Immunology
Academic article
2014
-
Fossmark, Reidar;
Sagatun, Liv;
Sandvik, Arne Kristian;
Waldum, Helge.
(2014)
Serum gastrin in relation to localization and histological sub-classification of non-cardia adenocarcinomas in the stomach.
Gastroenterology
Abstract
-
Sagatun, Liv;
Jianu, Constantin-Sergiu;
Fossmark, Reidar;
Mårvik, Ronald;
Nordrum, Ivar Skjåk;
Waldum, Helge.
(2014)
The gastric mucosa 25 years after proxiaml gastric vagotomy.
Scandinavian Journal of Gastroenterology
Academic article
Journal publications
-
Jørgensen, Kristin Kaasen;
Goll, Guro Løvik;
Sexton, Joseph;
Bolstad, Nils;
Olsen, Inge Christoffer;
Asak, Øivind Wessel.
(2020)
Efficacy and safety of CT-P13 in inflammatory bowel disease after switching from originator infliximab: Exploratory analyses from the NOR-SWITCH main and extension trials.
BioDrugs
Academic article
-
Mjønes, Patricia;
Sagatun, Liv;
Nordrum, Ivar Skjåk;
Waldum, Helge.
(2017)
Neuron-Specific Enolase as an Immunohistochemical
Marker Is Better Than Its Reputation.
Journal of Histochemistry and Cytochemistry
Academic article
-
Mjønes, Patricia;
Nordrum, Ivar Skjåk;
Sørdal, Øystein Finset;
Sagatun, Liv;
Fossmark, Reidar;
Sandvik, Arne Kristian.
(2017)
Expression of the cholecystokinin-B receptor in neoplastic gastric cells.
Discover Oncology
Academic article
-
Waldum, Helge;
Sagatun, Liv;
Mjønes, Patricia.
(2017)
Gastrin and gastric cancer.
Frontiers in Endocrinology
Academic article
-
Sagatun, Liv;
Mjønes, Patricia Gjertrud;
Jianu, Constantin-Sergiu;
Boyce, Malcolm;
Waldum, Helge Lyder;
Fossmark, Reidar.
(2016)
The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: Review of long-term treatment.
European Journal of Gastroenterology and Hepathology
Academic article
-
Boyce, Malcolm;
Moore, Andrew;
Sagatun, Liv;
Parsons, Bryony;
Varro, Andrea;
Campbell, Fiona.
(2016)
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
British Journal of Clinical Pharmacology
Academic article
-
Sagatun, Liv;
Fossmark, Reidar;
Jianu, Constantin-Sergiu;
Qvigstad, Gunnar;
Nordrum, Ivar Skjåk;
Mjønes, Patricia.
(2016)
Follow-up of patients with ECL cell-derived tumours.
Scandinavian Journal of Gastroenterology
Academic article
-
Fossmark, Reidar;
Sagatun, Liv;
Nordrum, Ivar Skjåk;
Sandvik, Arne Kristian;
Waldum, Helge.
(2015)
Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival.
APMIS - Journal of Pathologiy, Microbiology and Immunology
Academic article
-
Fossmark, Reidar;
Sagatun, Liv;
Sandvik, Arne Kristian;
Waldum, Helge.
(2014)
Serum gastrin in relation to localization and histological sub-classification of non-cardia adenocarcinomas in the stomach.
Gastroenterology
Abstract
-
Sagatun, Liv;
Jianu, Constantin-Sergiu;
Fossmark, Reidar;
Mårvik, Ronald;
Nordrum, Ivar Skjåk;
Waldum, Helge.
(2014)
The gastric mucosa 25 years after proxiaml gastric vagotomy.
Scandinavian Journal of Gastroenterology
Academic article
Knowledge Transfer
2018
-
Academic lectureBoyce, Malcolm; Moore, Andrew; Parsons, Bryony; Lloyd, Katy A.; Sagatun, Liv; Varro, Andrea. (2018) Netazepide, a gastrin/CCK2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis. North American Neuroendocrine Tumour Society North American Neuroendocrine Tumour Society NANETS , Seattle 2018-10-04 - 2018-10-06
2014
-
Academic lectureFossmark, Reidar; Sagatun, Liv; Sandvik, Arne Kristian; Waldum, Helge. (2014) Serum gastrin, lokalisering og histologisk subklassifikasjon av adenocarcinomer i ventrikkelen. Norsk gastroenterologisk forening Norsk gastroenterologisk forenings årsmøte , Lillehammer 2014-01-30 - 2014-02-01
-
PosterFossmark, Reidar; Sagatun, Liv; Sandvik, Arne Kristian; Waldum, Helge. (2014) Serum gastrin in relation to localization and histological sub-classification of non-cardia adenocarcinomas in the stomach. American Gastroenterological Association Digestive Disease Week , Chicago 2014-05-03 - 2014-05-06